Advances in Psychopharmacology for Anxiety Disorders
Garakani A, Murrough J, Iosifescu D. Advances in Psychopharmacology for Anxiety Disorders. FOCUS The Journal Of Lifelong Learning In Psychiatry 2014, 12: 152-162. DOI: 10.1176/appi.focus.12.2.152.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSerotonin-norepinephrine reuptake inhibitorsSelective serotonin reuptake inhibitorsPosttraumatic stress disorderAnxiety disordersReuptake inhibitorsRelated conditionsGamma-aminobutyric acid (GABA) systemPharmacological treatment modalitiesFirst-line treatmentSerotonin reuptake inhibitorsNew pharmacotherapeutic approachesNorepinephrine reuptake inhibitorsVasopressin receptor antagonistsNovel treatment optionsPrevalent psychiatric disordersGlutamate modulatorsMedication classesCertain anxiety disordersNeuropeptide YTreatment modalitiesTreatment optionsNew drug developmentReceptor antagonistNew medicationsPharmacotherapeutic approaches